We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

7 hedge funds and large institutions have $28K invested in PDL BioPharma, Inc. in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more capital invested

Capital invested by funds: $28K → $28K (+$3)

0% more funds holding

Funds holding: 7 → 7 (0)

Holders
7
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

PDLI Hedge Fund Activity: Q2 2025 in Review

7 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q2 2025, worth a combined $28K — up 0.01% from $28K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new PDLI positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

  • 7 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $28K of PDL BioPharma, Inc. stock for Q2 2025, up 0.01% quarter-over-quarter.
  • 1 fund opened new PDL BioPharma, Inc. positions in Q2 2025 and 0 closed out, a net change of +1 holder.

Based on aggregated 13F filings for Q2 2025.